We are live on ! Find out more
SNDX icon

Syndax Pharmaceuticals
SNDX

210 hedge funds and large institutions have $1.71B invested in Syndax Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 38 funds opening new positions, 86 increasing their positions, 58 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

58% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 24

48% more repeat investments, than reductions

Existing positions increased: 86 | Existing positions reduced: 58

7% more funds holding

Funds holding: 196 → 210 (+14)

1.76% more ownership

Funds ownership: 102.79% → 104.55% (+1.8%)

9% more call options, than puts

Call options by funds: $16.2M | Put options by funds: $14.9M

4% less capital invested

Capital invested by funds: $1.79B → $1.71B (-$80M)

18% less funds holding in top 10

Funds holding in top 10: 11 → 9 (-2)

Holders
210
Holders Change
+14
Holders Change %
+7.14%
% of All Funds
3.02%
Holding in Top 10
9
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-18.18%
% of All Funds
0.13%
New
38
Increased
86
Reduced
58
Closed
24
Calls
$16.2M
Puts
$14.9M
Net Calls
+$1.27M
Net Calls Change
-$2.89M

Top Buyers

1
BNP Paribas Asset Management
BNP Paribas Asset Management
France
+$16.3M
2
EAM
Eventide Asset Management
Massachusetts
+$16.3M
3
FTM
First Turn Management
California
+$11.3M
4
PCH
Polar Capital Holdings
United Kingdom
+$10.3M
5
EP
Eversept Partners
New York
+$10.2M

Top Sellers

1
Wellington Management Group
Wellington Management Group
Massachusetts
-$48.6M
2
SI
Sofinnova Investments
California
-$28.2M
3
APM
Avidity Partners Management
Texas
-$18.2M
4
Marshall Wace
Marshall Wace
United Kingdom
-$17.4M
5
ECM
ExodusPoint Capital Management
New York
-$6.35M
Name Holding Trade Value Shares
Change 		Change in
Stake
DekaBank Deutsche Girozentrale
126
DekaBank Deutsche Girozentrale
Germany
$521K – – –
SA
127
Sanctuary Advisors
Indiana
$498K +$639K +30,928 New
AQR Capital Management
128
AQR Capital Management
Connecticut
$489K -$38.3K -1,854 -7%
New York State Common Retirement Fund
129
New York State Common Retirement Fund
New York
$489K -$407K -19,714 -44%
BHCM
130
Brevan Howard Capital Management
Jersey
$437K +$469K +22,685 New
IIM
131
INTECH Investment Management
Florida
$429K +$460K +22,282 New
ASRS
132
Arizona State Retirement System
Arizona
$424K +$12.8K +618 +3%
Nomura Holdings
133
Nomura Holdings
Japan
$421K +$451K +21,849 New
II
134
Inspire Investing
Idaho
$410K +$83K +4,018 +23%
BNP Paribas Financial Markets
135
BNP Paribas Financial Markets
France
$406K +$344K +16,663 +376%
Canada Life
136
Canada Life
Manitoba, Canada
$398K – – –
ProShare Advisors
137
ProShare Advisors
Maryland
$396K -$228K -11,044 -35%
BC
138
Bridgefront Capital
Texas
$392K +$420K +20,346 New
CM
139
Caption Management
Oklahoma
$391K +$420K +20,326 New
Allianz Asset Management
140
Allianz Asset Management
Germany
$375K -$223K -10,800 -36%
Teacher Retirement System of Texas
141
Teacher Retirement System of Texas
Texas
$369K +$49.4K +2,389 +14%
State Board of Administration of Florida Retirement System
142
State Board of Administration of Florida Retirement System
Florida
$365K – – –
AI
143
Atria Investments
North Carolina
$364K +$391K +18,928 New
SPC
144
Sigma Planning Corp
Michigan
$361K -$4.13K -200 -1%
NRD
145
Nebula Research & Development
New York
$348K +$373K +18,070 New
A
146
AlphaQuest
New York
$344K +$87.2K +4,223 +31%
DnB Asset Management
147
DnB Asset Management
Norway
$334K +$86.6K +4,190 +32%
Stifel Financial
148
Stifel Financial
Missouri
$327K +$351K +16,976 New
Creative Planning
149
Creative Planning
Kansas
$318K -$39.9K -1,930 -10%
CUAMC
150
China Universal Asset Management Company
China
$315K +$132K +6,383 +64%
4 5
6
7 8

SNDX Hedge Fund Activity: Q3 2024 in Review

210 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Syndax Pharmaceuticals (SNDX) for Q3 2024, worth a combined $1.71B — down 4.5% from $1.79B a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new SNDX positions and 24 closed out — a net gain of 14 holders — while 86 added to existing stakes and 58 trimmed.

The largest buyer was BNP Paribas Asset Management, opening a new position worth an estimated $16.3M. The largest seller was Wellington Management Group, cutting an estimated $48.6M.

  • 210 institutional investors held Syndax Pharmaceuticals (SNDX) as of Q3 2024, up from 196 in Q2 2024.
  • Funds reported $1.71B of Syndax Pharmaceuticals stock for Q3 2024, down 4.5% quarter-over-quarter.
  • 38 funds opened new Syndax Pharmaceuticals positions in Q3 2024 and 24 closed out, a net change of +14 holders.
  • The largest Syndax Pharmaceuticals buyer in Q3 2024 was BNP Paribas Asset Management, an estimated $16.3M added.
  • The largest Syndax Pharmaceuticals seller in Q3 2024 was Wellington Management Group, an estimated $48.6M sold.

Based on aggregated 13F filings for Q3 2024.